Combined Determination of sTREM-1, PCT and CD64 in Diagnosing Sepsis

NCT02198950 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2020-09-18

No results posted yet for this study

Summary

The purpose of this study is to determine wether the combined measurement of the soluble form of TREM-1, PCT and the determination of neutrophils CD64 expression could diagnose sepsis in critically ill patients.

Conditions

  • Critically Ill Patients

Sponsors & Collaborators

  • Central Hospital, Nancy, France

    lead OTHER

Principal Investigators

  • Sebastien Gibot, MD, PhD · Central Hospital, Nancy, France

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2011-10-31
Completion
2011-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02198950 on ClinicalTrials.gov